The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Immeuble "Le Wilson"
70, avenue du General de Gaulle
The Orphan Europe was founded in 1990 with the overall aim to provide treatment for patients with unmet medical needs suffering from rare diseases. Orphan Europe was acquired by Recordati in December 2007. Today Orphan Europe markets nine orphan drugs and has a network of subsidiaries and offices throughout Europe and the Middle East. This network works closely with academics, patient associations and health care authorities to improve the quality of diagnosis and care of patients with rare disease.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.